FDA Inspection
Fresenius Kabi Deutschland GmbHFresenius Kabi Deutschland GmbH – FDA Inspection, Apr 11, 2018
Record Details
This FDA Inspection record concerns Fresenius Kabi Deutschland GmbH, with an inspection on April 11, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a511328c-d1e1-4fe6-9eac-399f6a3af0ed
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1050946
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Fresenius Kabi Deutschland GmbH
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 19, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 5, 2019 | Not classified | Office of Inspections and Investigations | |
| September 26, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fresenius Kabi Deutschland GmbH
- FDA Inspection 1208229 - 2022-10-19
- FDA Inspection 1103462 - 2019-09-05
- FDA Inspection 900868 - 2014-09-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.